drugset / Trial / NCT00005954

Temozolomide in Treating Patients With Brain Metastases

NCT00005954 ↗

Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of temozolomide in treating patients who have brain metastases.

Timeline

Start
2000-08
Primary completion
—
Completion
2003-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Temozolomide Small molecule — Oral